Open Access

[Retracted] Identification of circulating tumor cells with EML4‑ALK translocation using fluorescence in situ hybridization in advanced ALK‑positive patients with lung cancer

  • Authors:
    • Young Hun Kim
    • Eunjoo Hwang
    • Hye Seon Lee
    • Ji‑Hyun Uh
    • Myoung Shin Kim
    • Byung Hee Jeon
  • View Affiliations

  • Published online on: February 12, 2019     https://doi.org/10.3892/ol.2019.10032
  • Pages: 4044-4044
  • Copyright : © Kim et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

Related Articles

Journal Cover

April-2019
Volume 17 Issue 4

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Kim YH, Hwang E, Lee HS, Uh JH, Kim MS and Jeon BH: [Retracted] Identification of circulating tumor cells with EML4‑ALK translocation using fluorescence in situ hybridization in advanced ALK‑positive patients with lung cancer. Oncol Lett 17: 4044-4044, 2019.
APA
Kim, Y.H., Hwang, E., Lee, H.S., Uh, J., Kim, M.S., & Jeon, B.H. (2019). [Retracted] Identification of circulating tumor cells with EML4‑ALK translocation using fluorescence in situ hybridization in advanced ALK‑positive patients with lung cancer. Oncology Letters, 17, 4044-4044. https://doi.org/10.3892/ol.2019.10032
MLA
Kim, Y. H., Hwang, E., Lee, H. S., Uh, J., Kim, M. S., Jeon, B. H."[Retracted] Identification of circulating tumor cells with EML4‑ALK translocation using fluorescence in situ hybridization in advanced ALK‑positive patients with lung cancer". Oncology Letters 17.4 (2019): 4044-4044.
Chicago
Kim, Y. H., Hwang, E., Lee, H. S., Uh, J., Kim, M. S., Jeon, B. H."[Retracted] Identification of circulating tumor cells with EML4‑ALK translocation using fluorescence in situ hybridization in advanced ALK‑positive patients with lung cancer". Oncology Letters 17, no. 4 (2019): 4044-4044. https://doi.org/10.3892/ol.2019.10032